Product logins

Find logins to all Clarivate products below.


Obesity Interventions – Market Insights – Europe (Supplemental)

The European market for obesity interventions will grow through 2024, driven by increasing bariatric surgery procedure volumes—which will positively impact the unit sales of internal closure devices—and by growth in the intragastric balloon segment, because of the introduction of new products that will gain adoption.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the obesity interventions market in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…